Linear particle accelerators market seen reaching $3.53 billion by 2030

The global linear particle accelerators market is projected to grow from $2.73 billion in 2025 to $3.53 billion by 2030, driven by demand for precision cancer treatments, scientific research and nuclear medicine infrastructure. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Linear particle accelerators are central to cancer radiation therapy, high-energy physics and nuclear medicine. - Growth in precision medicine and targeted radiation is expanding demand for these systems. - The market’s projected rise signals continued investment in healthcare infrastructure and scientific research.

What happened: - The Business Research Company released an update on the global linear particle accelerators market on Aug. 14, 2026. - The report estimates the market will rise from $2.73 billion in 2025 to $2.9 billion in 2026. - The market is projected to reach $3.53 billion by 2030. - The report puts the forecast period CAGR at 5.1%.

The details: - Historical growth has been driven by rising global cancer incidence, expanded radiation oncology infrastructure and higher adoption of advanced radiotherapy techniques. - Increased government funding for scientific research facilities has also supported demand. - The market’s forecast growth reflects demand for cutting-edge cancer treatment technologies and precision radiation therapies. - The report also points to growing investment in nuclear medicine infrastructure and particle physics research programs. - Key trends expected during the forecast period include wider use of linear accelerators in cancer radiation therapy, broader nuclear medicine applications and more compact modular accelerator systems. - A linear particle accelerator speeds up charged particles such as electrons, protons or ions to very high velocities. - These systems are used in high-energy physics, nuclear physics and medical radiation therapy. - A free sample of the report is available here. - The full report is available here.

Between the lines: - Precision medicine is becoming a stronger market driver because it favors more individualized treatment approaches. - The report cites FDA approvals for personalized treatments as an indicator of that shift, including 16 new personalized treatments for rare diseases in 2023 versus six in 2022. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region through the forecast period.

What's next: - Demand is likely to keep climbing as cancer therapy continues shifting toward more targeted and precise treatment. - The report expects broader adoption of linear accelerators in both healthcare and research settings. - The Business Research Company’s 2026 report edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel forecasting dashboards and market hotspots infographics.

The bottom line: - Linear particle accelerators are moving from a niche scientific tool to a broader growth market tied to cancer care, nuclear medicine and advanced research.